Recent advances in cutaneous melanoma: towards a molecular model and targeted treatment
Author:
Affiliation:
1. Wesley Clinical School; The Wesley Hospital; Brisbane; Queensland; Australia
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajd.12013/fullpdf
Reference101 articles.
1. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma;Middleton;J. Clin. Oncol.,2000
2. Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group;Atkins;J. Clin. Oncol.,2008
3. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials;Korn;J. Clin. Oncol.,2008
4. Phase II study of extended-dose temozolomide in patients with melanoma;Rietschel;J. Clin. Oncol.,2008
5. Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial;Wierzbicka-Hainaut;Melanoma Res.,2009
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antitumor effect of cell therapy with mesenchymal stem cells on murine melanoma B16-F10;Biomedicine & Pharmacotherapy;2020-08
2. LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis;Cancer Cell International;2020-01-10
3. Nanomedicine as a potent strategy in melanoma tumor microenvironment;Pharmacological Research;2017-12
4. Circulating melanoma cells as a potential biomarker to detect metastasis and evaluate prognosis;Australasian Journal of Dermatology;2016-03-01
5. Surgical treatment of a metastatic melanoma patient after targeted therapy;Russian Journal of Oncology;2015-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3